Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 7/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | NPY2R | P49146 | 7/20 | 0.54 |
| ▸ | NPY4R | P50391 | 7/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.54 |
| ▸ | CALCR | P30988 | 4/20 | 0.54 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.53 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30233341 | 0.95 | NPY1R (0.57) | NPY1ROPRD1OPRM1NPY2RNPY4R | |
| SCHEMBL30233254 | 0.92 | OPRD1 (0.61) | OPRD1OPRM1CALCRNMUR2NMUR1 | |
| SCHEMBL29471031 | 0.91 | NPY1R (0.54) | NPY1ROPRD1NPY2RNPY4RNPY5R | |
| SCHEMBL30753761 | 0.91 | OPRD1 (0.61) | OPRD1OPRM1CALCRNMUR2NMUR1 | |
| SCHEMBL30233475 | 0.90 | OPRD1 (0.59) | OPRD1OPRM1CALCRNMUR2NMUR1 | |
| SCHEMBL30788354 | 0.87 | TFPI (0.55) | OPRD1OPRM1NMUR2NMUR1 | |
| SCHEMBL30788346 | 0.86 | TFPI (0.56) | OPRD1OPRM1NMUR2NMUR1 | |
| SCHEMBL30233411 | 0.85 | CALCR (0.63) | OPRD1OPRM1CALCR | |
| SCHEMBL30788361 | 0.85 | NMUR2 (0.56) | OPRD1OPRM1NMUR2NMUR1 | |
| SCHEMBL38660346 | 0.84 | OPRD1 (0.62) | NPY1ROPRD1OPRM1NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115702161-A | Peptide compositions and methods for inhibiting nicotinic acetylcholine receptor activity | 格罗制药公司 | 2023-02-14 | — | — | CN | disclosed |